These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16092164)

  • 1. [Chronic pulmonary berylliosis: a model of interaction between environment and genetic predisposition (Part 1). Mineralogy, toxicology, epidemiology and risk factors].
    Marchand-Adam S; Valeyre D
    Rev Mal Respir; 2005 Apr; 22(2 Pt 1):257-69. PubMed ID: 16092164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
    Crooks J; Mroz MM; VanDyke M; McGrath A; Schuler C; McCanlies EC; Virji MA; Rosenman KD; Rossman M; Rice C; Monos D; Fingerlin TE; Maier LA
    Occup Environ Med; 2022 Feb; 79(2):120-126. PubMed ID: 34535537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and exposure risks for chronic beryllium disease.
    Maier LA
    Clin Chest Med; 2002 Dec; 23(4):827-39. PubMed ID: 12516537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA; McGrath DS; Sato H; Lympany P; Welsh K; Du Bois R; Silveira L; Fontenot AP; Sawyer RT; Wilcox E; Newman LS
    J Immunol; 2003 Dec; 171(12):6910-8. PubMed ID: 14662898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
    McCleskey TM; Buchner V; Field RW; Scott BL
    Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2)].
    Marchand-Adam S; Guillon F; Brauner M; Valeyre D
    Rev Mal Respir; 2005 Apr; 22(2 Pt 1):271-87. PubMed ID: 16092165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DPB1 and chronic beryllium disease: a HuGE review.
    McCanlies EC; Kreiss K; Andrew M; Weston A
    Am J Epidemiol; 2003 Mar; 157(5):388-98. PubMed ID: 12615603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.
    Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Cragle DL; Tankersley WG; Wells SM; Newman LS; Maier LA
    Occup Environ Med; 2011 Nov; 68(11):842-8. PubMed ID: 21460389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
    Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Fingerlin TE; Sato H; Newman LS; Maier LA
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1680-8. PubMed ID: 21471109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z; White PS; Petrovic M; Tatum OL; Newman LS; Maier LA; Marrone BL
    J Immunol; 1999 Aug; 163(3):1647-53. PubMed ID: 10415070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.
    Amicosante M; Berretta F; Rossman M; Butler RH; Rogliani P; van den Berg-Loonen E; Saltini C
    Respir Res; 2005 Aug; 6(1):94. PubMed ID: 16098233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic difficulties of chronic pulmonary berylliosis in France].
    Ghanem M; Naccache JM; Bonneterre V; L'huillier JP; Guillaud Segard B; Lazor R; Tazi A; Gondouin A; Israël-Biet D; Marquignon MF; Cottin V; Valeyre D; Marchand-Adam S
    Rev Mal Respir; 2020 May; 37(5):364-368. PubMed ID: 32279890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD; Rossman M; Hertzberg V; Reilly MJ; Rice C; Kanterakis E; Monos D
    Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenetic basis of environmental lung disease: lessons from the berylliosis model.
    Saltini C; Amicosante M; Franchi A; Lombardi G; Richeldi L
    Eur Respir J; 1998 Dec; 12(6):1463-75. PubMed ID: 9877510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
    Maier L; Martyny J; Mroz M; McGrath D; Lympany P; duBois R; Zhang L; Murphy J; Newman LS
    Chest; 2002 Mar; 121(3 Suppl):81S. PubMed ID: 11893702
    [No Abstract]   [Full Text] [Related]  

  • 16. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
    Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
    Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of an Exposure Response and Interaction With HLA-DPβ1 and DRβ1 Polymorphisms in the Development of Beryllium Toxicity in a High Beryllium Exposure Cohort.
    Widyaningsih V; Rosenman K; Reilly MJ; Wang L; Pathak DR; Gardiner JC; Rice C; Monos D; Rossman M
    J Occup Environ Med; 2020 Jan; 62(1):64-73. PubMed ID: 31743304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
    Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.